A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan.

Atherosclerosis / epidemiology Biomarkers / blood Blood Glucose / analysis Cardiovascular Diseases / epidemiology Cholesterol / blood Coronary Artery Disease / epidemiology Diabetes Mellitus / epidemiology Humans Hypertension / epidemiology Practice Guidelines as Topic Risk Assessment Risk Factors Taiwan / epidemiology
Atherosclerosis Performance guide Risk factors

Journal

Journal of the Formosan Medical Association = Taiwan yi zhi
ISSN: 0929-6646
Titre abrégé: J Formos Med Assoc
Pays: Singapore
ID NLM: 9214933

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 07 01 2019
revised: 12 02 2019
accepted: 10 04 2019
pubmed: 23 5 2019
medline: 20 3 2020
entrez: 23 5 2019
Statut: ppublish

Résumé

Atherosclerotic cardiovascular disease (ASCVD), including coronary artery disease, cerebrovascular disease, and peripheral artery disease, carries a high morbidity and mortality. Risk factor control is especially important for patients with ASCVD to reduce recurrent cardiovascular events. Clinical guidelines have been developed by the Taiwan Society of Cardiology, Taiwan Society of Lipids and Atherosclerosis, and Diabetes Association of Republic of China (Taiwan) to assist health care professionals in Taiwan about the control of hypertension, hypercholesterolemia and diabetes mellitus. This article is to highlight the recommendations about blood pressure, cholesterol, and sugar control for ASCVD. Some medications that are beneficial for ASCVD were also reviewed. We hope the clinical outcomes of ASCVD can be improved in Taiwan through the implementation of these recommendations.

Identifiants

DOI: 10.1016/j.jfma.2019.04.007 PMID: 31113748
pubmed: 31113748
pii: S0929-6646(19)30003-8
doi: 10.1016/j.jfma.2019.04.007
pii:
doi:

Substances chimiques

Biomarkers 0
Blood Glucose 0
Cholesterol 97C5T2UQ7J

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

674-684

Informations de copyright

Copyright © 2019. Published by Elsevier B.V.

Auteurs

Yi-Heng Li (YH)

Division of Cardiology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

Jaw-Wen Chen (JW)

Department of Medical Research and Education, Taipei Veterans General Hospital and Institute of Pharmacology, National Yang Ming University, Taipei, Taiwan.

Tsung-Hsien Lin (TH)

Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital and Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.

Yu-Chen Wang (YC)

Division of Cardiology, Department of Internal Medicine, Asia University Hospital, China Medical University College of Medicine and Hospital, Taichung, Taiwan.

Chau-Chung Wu (CC)

Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital and Graduate Institute of Medical Education & Bioethics, College of Medicine, National Taiwan University, Taipei, Taiwan.

Hung-I Yeh (HI)

Department of Internal Medicine and Medical Research, Mackay Memorial Hospital, Taipei, Taiwan; Department of Medicine, Mackay Medical College, New Taipei City, Taiwan.

Chin-Chou Huang (CC)

Department of Medical Education, Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan.

Kuan-Cheng Chang (KC)

Division of Cardiovascular Medicine, Department of Internal Medicine, China Medical University Hospital and College of Medicine, China Medical University, Taichung, Taiwan.

Cho-Kai Wu (CK)

Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.

Po-Wei Chen (PW)

Division of Cardiology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

Chen-Wei Huang (CW)

Division of Cardiology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

Zhih-Cherng Chen (ZC)

Division of Cardiology, Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan; Department of Pharmacy, Chia Nan University of Pharmacy & Science, Tainan, Taiwan.

Wei-Ting Chang (WT)

Division of Cardiology, Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan.

Wei-Chun Huang (WC)

Division of Cardiology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.

Chih-Yuan Wang (CY)

Division of Endocrinology and Metabolism, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.

Mei-Yueh Lee (MY)

Division of Endocrinology and Metabolism, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Taiwan; Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.

A-Ching Chao (AC)

Department of Neurology, Kaohsiung Medical University Hospital, Taiwan; Graduate Institute of Clinical Medicine and Department of Neurology, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.

Wei-Ren Fu (WR)

Department of Neurology, Mackay Memorial Hospital, Taipei, Taiwan.

Li-Kai Tsai (LK)

Stroke Center and Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan.

Sung-Chun Tang (SC)

Stroke Center and Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan.

Hsin-Lung Chan (HL)

Department of Family Medicine, Mackay Memorial Hospital, Department of Medicine, Mackay Medical College, Taipei, Taiwan.

Yi-Ching Yang (YC)

Department of Family Medicine, National Cheng Kung University Hospital, Department of Family Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.

Yen-Wen Wu (YW)

Cardiology Division, Cardiovascular Medical Center, Far Eastern Memorial Hospital, New Taipei City, Taiwan; National Yang-Ming University School of Medicine, Taipei, Taiwan.

Juey-Jen Hwang (JJ)

Cardiology Division, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan; Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital Yun-Lin, Yun-Lin, Taiwan. Electronic address: jueyhwang@ntu.edu.tw.

Jiunn-Lee Lin (JL)

Cardiology Division, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan; Division of Cardiovascular Medicine, Department of Internal Medicine, Taipei Medical University Shuang Ho Hospital, New Taipei City, Taiwan. Electronic address: jiunnleelin@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Maladies cardiovasculaires › Maladies vasculaires › Artériopathies oblitérantes › Artériosclérose › Athérosclérose › A performance guide for major risk factors...
questionsmedicales.fr › Facteurs biologiques › Marqueurs biologiques › A performance guide for major risk factors...
questionsmedicales.fr › Glucides › Sucres › Oses › Hexose › Glucose › Glycémie › A performance guide for major risk factors...
questionsmedicales.fr › Maladies cardiovasculaires › A performance guide for major risk factors...
questionsmedicales.fr › Lipides › Lipides membranaires › Stérols › Cholestérol › A performance guide for major risk factors...
questionsmedicales.fr › Maladies cardiovasculaires › Maladies vasculaires › Ischémie myocardique › Maladie coronarienne › Maladie des artères coronaires › A performance guide for major risk factors...
questionsmedicales.fr › Maladies endocriniennes › Diabète › A performance guide for major risk factors...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › A performance guide for major risk factors...
questionsmedicales.fr › Maladies cardiovasculaires › Maladies vasculaires › Hypertension artérielle › A performance guide for major risk factors...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Assurance de la qualité des soins de santé › Recommandations comme sujet › Guides de bonnes pratiques cliniques comme sujet › A performance guide for major risk factors...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Appréciation des risques › A performance guide for major risk factors...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Facteurs de risque › A performance guide for major risk factors...
questionsmedicales.fr › Régions géographiques › Iles › Taïwan › A performance guide for major risk factors...